for neural formation. By studying the regulation of Sox2 and Sox3, we hope to identify the molecular mechanisms that drive the expression of early neural genes. Animal cap assays were performed in the presence of the protein synthesis inhibitor cycloheximide to determine if de novo protein synthesis is required for the repression or expression of Sox2 and Sox3. Dominant negative Xfz8, TCF3 and FGF receptor were overexpressed to expose the roles of FGF and Wnt in early neural induction. Transient reporter assays were used to assess the level of activity of the 1.5 kb Sox3 upstream regulatory region. Analysis of transgenic embryos was used to define a cis-element in Sox3 required for repression, and computational analysis was used to identify candidate regulatory proteins in that element. The role of these candidate proteins Sox3 regulation is being tested. The results from these experiments along with current research suggest that Sox2 and Sox3 have distinct modes of regulation, though they have very similar expression patterns.
for neural formation. By studying the regulation of Sox2 and Sox3, we hope to identify the molecular mechanisms that drive the expression of early neural genes. Animal cap assays were performed in the presence of the protein synthesis inhibitor cycloheximide to determine if de novo protein synthesis is required for the repression or expression of Sox2 and Sox3. Dominant negative Xfz8, TCF3 and FGF receptor were overexpressed to expose the roles of FGF and Wnt in early neural induction. Transient reporter assays were used to assess the level of activity of the 1.5 kb Sox3 upstream regulatory region. Analysis of transgenic embryos was used to define a cis-element in Sox3 required for repression, and computational analysis was used to identify candidate regulatory proteins in that element. The role of these candidate proteins Sox3 regulation is being tested. The results from these experiments along with current research suggest that Sox2 and Sox3 have distinct modes of regulation, though they have very similar expression patterns. The BTB/POZ zinc finger (POZ-ZF) family of transcription factors plays diverse roles in development and cancer. These proteins have a highly conserved, amino-terminal protein -protein interaction POZ domain and a DNAbinding, zinc finger domain at their carboxy-terminus. The POZ domain mediates homo-and heterodimerization with other POZ-ZF proteins and recruits histone deacetylase corepressor complexes. We study two POZ-ZF proteins: the dual-specificity transcription repressor Kaiso that interacts with the beta-catenin-like protein p120-catenin (p120 ctn ) and Znf131, an uncharacterized POZ-ZF protein that heterodimerizes with Kaiso and also appears to interact with p120 ctn . Recently, in Xenopus, p120 ctn and Kaiso were linked to the canonical and non-canonical Wnt signaling pathways via their regulation of known Wnt gene targets. Like Kaiso, Znf131 transcripts appear enriched in the developing central nervous system and adult brain, and preliminary morpholino knock-down experiments in Xenopus revealed central nervous tissue defects. Our hypothesis is that Znf131 is required in vertebrate embryogenesis especially during neural development. We are currently using morpholino knock-down and over-expression approaches to assess the developmental roles of Xenopus Znf131 in more detail. We will also determine whether Znf131, like Kaiso, participates in regulating canonical (Wnt/beta-catenin/TCF) Wnt target genes and whether p120 ctn displaces Znf131 from gene promoters to cause the transcriptional activation of developmentally important genes. The adoption of a correct neurotransmitter phenotype by neurons during development is essential for proper functioning of the adult nervous system. The molecular mechanisms controlling the establishment of a final neurotransmitter phenotype are key issues in the field. Glutamic acid decarboxylase (GAD) is the enzyme responsible for synthesizing GABA, the major inhibitory neurotransmitter present in the central nervous system, and is widely used as a marker for GABAergic neurons. To elucidate the molecular basis of GAD67 expression and analyze the regulatory elements required for its proper expression during neural development, we have cloned and functionally characterized the gene's upstream regulatory regions in Xenopus laevis. Analyses of transgenic embryos containing truncated upstream regions reveal a number of discrete elements required for GAD67 expression in specific regions of the nervous system. A short region located proximal to the transcriptional start site is sufficient to drive GFP expression in the retina in a pattern identical to endogenous GAD67. In contrast, the regulatory elements required for proper GAD67 expression in the anterior central nervous system are located further upstream. The identification of the regulatory elements required to reproduce the complete endogenous GAD67 expression pattern will allow real-time monitoring of the GABAergic phenotype in transgenic embryos following exposure to extracellular effector molecules or pharmacological treatment with drugs. 
